Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,653Revenue $M7.0Net Margin (%)-667.6Z-Score48.7
Enterprise Value $M1,516EPS $-0.6Operating Margin %-672.6F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-667.6Higher ROA y-yY
Price/Book13.210-y EBITDA Growth Rate %0Quick Ratio7.5Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio7.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-76.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-102.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M91.5ROI % (ttm)-34.8Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 18.1928%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 18.1921%New holding, 6310850 sh.6,310,850
KERXJohn Burbank 2012-12-31 Sold Out -0.06%$2.31 - $3.14
($2.72)
$ 18.19569%Sold Out0
KERXJohn Burbank 2012-09-30 Buy 0.06%$1.79 - $2.83
($2.08)
$ 18.19774%New holding, 500000 sh.500,000
KERXGeorge Soros 2006-09-30 Sold Out -0.04%$9.8 - $13.84
($12.1)
$ 18.1950%Sold Out0
KERXGeorge Soros 2006-06-30 Buy 0.04%$12.64 - $17.44
($15.3)
$ 18.1919%New holding, 30000 sh.30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
KERX Seth Klarman 2014-06-3010,539,98611.532.6+67.01%
Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENTSUR RONCEO 2014-07-07Sell1,788$15.7515.49view
Oliviero James F IIICFO 2014-07-07Sell2,054$15.7515.49view
BENTSUR RONCEO 2014-04-03Sell1,816$16.4610.51view
Oliviero James F IIICFO 2014-04-03Sell2,087$16.4610.51view
Oliviero James F IIICFO 2014-03-21Sell292,483$15.1420.15view
Oliviero James F IIICFO 2014-01-03Sell6,309$12.5744.71view
BENTSUR RONCEO 2014-01-03Sell5,257$12.5744.71view
Oliviero James F IIICFO 2013-12-30Sell109,500$12.6443.91view
BENTSUR RONCEO 2013-10-03Sell2,505$10.2577.46view
Oliviero James F IIICFO 2013-10-03Sell1,475$10.2577.46view

Press Releases about KERX :

    Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sel Aug 14 2014 
    Seth Klarman Tops Guru Scoreboard for First Half 2014 Jul 05 2014 
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD Mar 24 2014 
    Weekly Insider Sells Highlight: FLT, KERX, KOG, MEI, HTZ Jan 06 2014 
    comment on KERX Mar 02 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Bio drug Nov 03 2011 
    comment on KERX Oct 26 2011 


    More From Other Websites
    Your September Biotech Back-to-School Calendar Aug 26 2014
    Keryx Biopharmaceuticals (KERX) in Focus: Stock Adds 8.4% in Session Aug 26 2014
    Barbarian At The Gate: Keryx Biopharmaceuticals (KERX) Aug 25 2014
    KERYX BIOPHARMACEUTICALS INC Financials Aug 15 2014
    Seth Klarman's The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, ... Aug 14 2014
    Coverage initiated on Keryx Biopharma by FBR Capital Aug 14 2014
    H.C. Wainwright & Co. Believes Keryx Biopharmaceuticals Remains Undervalued Aug 08 2014
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2014
    Q2 2014 Keryx Biopharmaceuticals, Inc. Earnings Release - Before Market Open Aug 07 2014
    Keryx Biopharmaceuticals, Inc. Announces Second Quarter and Six Month 2014 Financial Results Aug 07 2014
    Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2014 Financial Results Aug 05 2014
    Keryx drug improves phosphorus, iron in kidney patients -trial Jul 24 2014
    Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the... Jul 24 2014
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 24 2014
    Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains Jun 24 2014
    Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally... Jun 18 2014
    Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference Jun 17 2014
    The Baupost Group buys a new position in Keryx Biopharmaceuticals Jun 06 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK